Recursion Pharmaceuticals (RXRX) is a clinical-stage biotechnology company utilizing artificial intelligence to expedite drug ...

Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...

The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key ...

A Wisconsin couple is suing Walgreens and a pharmacy benefits company alleging their son died because he couldn't afford a sudden $500 jump in the cost of his asthma medication.

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.

With this acquisition, LipoVation becomes a wholly owned subsidiary of Revium Rx, aligning with the company’s renewed commitment to drug delivery innovation. Revium Rx is developing a portfolio of ...

“At a time when fundamental rights are under attack across the country, we are doubling down on our commitment to safeguard ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is l ikely to drive up the cost of generic ...

Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

A grand jury in Baton Rouge, Louisiana, has indicted and issued arrest warrants for a New York physician who prescribed ...

Obesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids. The Food and Drug Administration approved the pill from Vertex ...